Summary
This Global Burden of Disease 2019 collaborative study synthesised epidemiological data from multiple sources to estimate the incidence of six major immune-mediated inflammatory diseases across 204 countries and territories. The analysis provides updated quantification of IMID disease burden to support public health prioritisation and health systems planning. The work represents a systematic effort to characterise the distribution and scale of IMIDs in contemporary global populations.
Regional applicability
The findings establish comparative incidence benchmarks that contextualise IMID burden in the United Kingdom within global and regional patterns, potentially informing NHS service planning and preventive health strategies. The data may identify whether UK IMID incidence differs materially from comparable high-income nations.
Key measures
Age-standardised incidence rates (ASIRs) for six major IMIDs; geographic and temporal variation in disease incidence; absolute numbers of incident cases globally, regionally, and nationally
Outcomes reported
The study quantified the global, regional, and national incidence of six major immune-mediated inflammatory diseases (IMIDs), providing disease burden estimates across diverse populations and geographic settings. Incidence data were synthesised to inform comparative epidemiological understanding of IMIDs worldwide.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.